Multiple proteasome subunits (e.g., PSMA1, PSMA5, PSMA6, PSMA7, and PSMB1) were upregulated in COVID-19 patients, especially during the acute phase of disease, potentially contributing to the dysregulation of proteasome activity (Fig. 2H). The gene discussed is PSMA5; the disease is COVID-19.